Cellular (T-cell) immunity against the virus that causes Covid-19 is likely to be present within most adults six months after primary infection, with levels considerably higher in patients with symptoms, a study suggests.

The data offers another piece of the puzzle that could be key to understanding whether previous Sars-CoV-2 infections – the virus behind Covid-19 – can prevent reinfection, and if so, for how long.

The study, led by the UK coronavirus immunology consortium, evaluated 100 non-hospitalised healthcare workers in March and April after antibody responses were detected in them. It is yet to be peer-reviewed.

It is the first study to offer data on T-cell levels six months after infection in people with mild or asymptomatic disease that is likely to represent the majority of infections, the authors say.

The results of the study are likely to be viewed positively, after previous studies suggested antibody levels can decline within the first few months post-infection.

Data released from a 100,000-person sample in August indicated about 6% of the population of England had antibodies – proteins produced in response to an infection – but antibody levels dropped by more than a quarter in three months, researchers revealed in late October.

Once the virus enters the body, it is greeted by a cavalry of cells that mount a counterattack that is swift, broad and generic. This so-called innate immune system is meant to arrest the infection in its tracks. If that mission is foiled, it buys time until the “experts” show up.

These experts constitute two types of white blood cells: B-cells and T-cells, that work like brothers-in-arms. If the virus makes it past the initial assault, some T-cells are slayers, annihilating respiratory cells the pathogen has colonised.

Meanwhile, helper T-cells take on a supportive role – including stimulating B-cells to produce molecules called antibodies that render the virus immobile or thwart it from penetrating other cells. The adaptive system also retains memory – but in the case of Covid-19, it is unclear how much and for how long.

After being tracked for six months, researchers found that every person had detectable T-cell levels, and levels were 50% higher in people who had experienced symptoms at the time of infection.

This could mean that either there will be more protection in people with more severe initial disease, or conversely, that people with asymptomatic disease are able to control the virus with lower levels of T-cells, they said.

A bigger set of patients would be tracked for a longer time period to a get a better sense of cellular immunity, given that T-cells could survive for long periods, said one of the study’s authors, Paul Moss, a professor at the University of Birmingham.

The authors also saw that T-cells levels were strongly correlated with the peak level of the antibody response. Cellular immune responses could even help to protect against the decline in antibody levels over time, they added.

Overall, the results offer evidence that T-cell immunity may last longer than antibodies – but whether these persistent T-cells offer protection against reinfection remains unclear.

“I think this data is reassuring, potentially even encouraging — but it does not mean that people cannot get reinfected,” Moss said. “We now need large-scale population studies to show how the antibody and cellular profiles act together to protect people over time.”

In the study, some people lost detectable levels of antibodies. But that did not mean that B-cells, which make antibodies, were not around to spring into action if challenged again, the authors explained.

Ideally, testing for B-cells and T-cells in the community would provide a conclusive idea of how much the antibody response was actually predicting large-scale immunity, and whether there were people who did not have antibodies but were protected by cellular immunity, cautioned the author Shamez Ladhani, a consultant epidemiologist for Public Health England.

“But at the moment, there is little evidence to suggest that there is widespread cell-mediated immunity without an antibody response.”

Paul Morgan, a professor at Cardiff University, who was not involved in the study, said: “The work provides a welcome dose of optimism that Sars-CoV2 infection (and immunisation?) can induce a robust and sustained protective immune response, although this does not yet prove immunity to further infections which will require longer-term surveillance and larger cohorts.”


Natalie Grover

The GuardianTramp

Related Content

Article image
Scientists whose work enabled mRNA Covid vaccine win medicine Nobel prize
Katalin Karikó and Drew Weissman share £823,000 prize announced by Nobel Assembly at the Karolinska Institute in Stockholm

Linda Geddes Science correspondent

02, Oct, 2023 @12:17 PM

Article image
Coronavirus vaccine: Oxford team aim to start lab-controlled human trial soon
Jenner Institute at Oxford looks to recruit healthy volunteers for controversial ‘challenge trial’

Hannah Devlin Science correspondent

16, Jul, 2020 @4:11 PM

Article image
French tests show even mild coronavirus illness leads to antibodies
Study raises hope of immunity even for those without severe symptoms

Peter Beaumont

27, May, 2020 @3:52 PM

Article image
Antibodies in breast milk remain for 10 months after Covid infection – study
Researchers believe such antibodies could be used to treat people with severe coronavirus

Linda Geddes

27, Sep, 2021 @5:00 AM

Article image
Coronavirus distancing may need to continue until 2022, say experts
Scientists say one-time lockdown will not bring pandemic under control

Hannah Devlin Science correspondent

14, Apr, 2020 @6:44 PM

Article image
Anger at plans to roll back Covid vaccines to under-11s in England
Children aged 5-11 will no longer be offered Covid jabs, except those in clinical risk groups, UKHSA confirms

Nicola Davis Science correspondent

06, Sep, 2022 @2:38 PM

Article image
‘We haven’t finished the job’: JVT reflects on 18 months of Covid
Exclusive: Listen to the experts, says deputy chief medical officer Jonathan Van-Tam, not the celebrities

Nicola Davis Science correspondent

24, Sep, 2021 @10:32 AM

Article image
‘The wondrous map’: how unlocking human DNA changed the course of science
Thanks to the success of the Human Genome Project, 20 years ago this week, scientists can track biology and disease at a molecular level

Robin McKie

21, Jun, 2020 @7:19 AM

Article image
Public health measures are key to curbing Covid in UK, say scientists
On the second anniversary of the first lockdown, experts including Wellcome Trust director Jeremy Farrar, outline what needs to be done to cope with pandemics

James Tapper and Michael Savage

20, Mar, 2022 @8:30 AM

Article image
Remdesivir has very little effect on Covid-19 mortality, WHO finds
Results of major trial described as sobering, with drug found not to improve survival rates

Sarah Boseley Health editor

16, Oct, 2020 @12:00 PM